» Articles » PMID: 35117031

Analysis of Volatile Organic Compounds Released from SW480 Colorectal Cancer Cells and the Blood of Tumor-bearing Mice

Overview
Specialty Oncology
Date 2022 Feb 4
PMID 35117031
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Volatile organic compound (VOC) analysis provides an elegant approach for colorectal cancer screening. An organic compound with a high vapor pressure or volatility can be detected in the headspace of cancer cells or blood samples. Therefore, analyzing VOCs in the blood of rats inoculated with colorectal cancer tissue and in SW480 medium from cultured colorectal cancer cells may provide accurate results.

Methods: After collecting venous blood from rats inoculated with cancer cells at different times, the cancer tissue was removed from the inoculated rats, and the medium was harvested from the cancer cells and cultured in the presence or absence of a chemotherapy drug of intestinal epithelial cells. We used solid-phase microextraction-gas chromatography-mass spectrometry (SPME-GC-MS) to analyze the headspace of the blood and media to evaluate the VOC profiles. Statistical analysis was conducted using principal component analysis (PCA) and orthogonal partial least-squares analysis (OP-LSDA).

Results: The and analyses of the colorectal cancer samples revealed a variety of compounds, such as cyclohexanone, 1-hexanol, 2-ethyl-, butylated hydroxytoluene, cyclotrisiloxane, hexamethyl-, pentanoic acid, 2,2,4-trimethyl-3-hydroxy-isobutyl ester and acetone. Butylated hydroxytoluene is unique with regard to its presence during tumor growth and resection; it is also present during tumor cell growth and necrosis. Acetone showed unique trends in the in vivo experimental group.

Conclusions: By analyzing VOC fingerprints related to colorectal cancer (CRC), we found that butylated hydroxytoluene and acetone have unique signatures that may provide the basis for clinical diagnosis and disease assessment.

Citing Articles

Exhaled volatile organic compounds for cholangiocarcinoma diagnosis.

Siriwong N, Sukaram T, Tansawat R, Apiparakoon T, Tiyarattanachai T, Marukatat S Liver Res. 2025; 6(3):191-197.

PMID: 39958199 PMC: 11791817. DOI: 10.1016/j.livres.2022.09.001.


Effect of HO induced oxidative stress on volatile organic compounds in differentiated 3T3-L1 cells.

Oyerinde A, Selvaraju V, Boersma M, Babu J, Geetha T Sci Rep. 2025; 15(1):2597.

PMID: 39833444 PMC: 11747074. DOI: 10.1038/s41598-025-86778-2.


Soil volatilomics uncovers tight linkage between soybean presence and soil omics profiles in agricultural fields.

Kuchikata H, Sano M, Fujiwara F, Murashima K, Kumaishi K, Narukawa M Sci Rep. 2024; 14(1):20541.

PMID: 39232061 PMC: 11375131. DOI: 10.1038/s41598-024-70873-x.


Identification of breath volatile organic compounds to distinguish pancreatic adenocarcinoma, pancreatic cystic neoplasm, and patients without pancreatic lesions.

Tiankanon K, Pungpipattrakul N, Sukaram T, Chaiteerakij R, Rerknimitr R World J Gastrointest Oncol. 2024; 16(3):894-906.

PMID: 38577457 PMC: 10989381. DOI: 10.4251/wjgo.v16.i3.894.


Urinary VOCs as biomarkers of early stage lung tumour development in mice.

Gouzerh F, Vigo G, Dormont L, Buatois B, Herve M, Mancini M Cancer Biomark. 2023; 39(2):113-125.

PMID: 37980646 PMC: 11002722. DOI: 10.3233/CBM-230070.


References
1.
Wang D, Wang C, Pi X, Guo L, Wang Y, Li M . Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma. Biomed Rep. 2016; 5(1):68-72. PMC: 4906617. DOI: 10.3892/br.2016.686. View

2.
Wang C, Dong R, Wang X, Lian A, Chi C, Ke C . Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Sci Rep. 2014; 4:7312. PMC: 4258651. DOI: 10.1038/srep07312. View

3.
Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E . Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther. 2009; 29(8):906-17. DOI: 10.1111/j.1365-2036.2009.03946.x. View

4.
Chen S . Aromatase and breast cancer. Front Biosci. 1998; 3:d922-33. DOI: 10.2741/a333. View

5.
Terelius Y, Ingelman-Sundberg M . Metabolism of n-pentane by ethanol-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. Eur J Biochem. 1986; 161(2):303-8. DOI: 10.1111/j.1432-1033.1986.tb10447.x. View